Enzon Pharmaceuticals, Inc.

    Jurisdiction
    United States
    LEI
    529900VN48L8QCMVPV36
    ISIN
    US2939041081 (ENZN)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €0.00
    Gross margin
    0.0%
    EBIT
    -€2.76M
    EBIT margin
    0.0%
    Net income
    -€1.14M
    Net margin
    0.0%

    Statement period: - (published )

    Dividends

    Last dividend amount
    $0.12
    Ex date
    Payment date

    Add to watchlist

    Notifications